Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Clovis Oncology, Inc. | President and Chief Executive Officer, Director | Stock Option (right to buy) | 80K | Mar 1, 2022 | Direct | ||
Flexion Therapeutics Inc | Director | Common Stock | 0 | $8.50 | Nov 19, 2021 | Direct | |
Flexion Therapeutics Inc | Director | Stock option (right to buy) | 0 | Nov 19, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLVS | Clovis Oncology, Inc. | Mar 1, 2022 | 3 | $0 | 4 | Mar 3, 2022 | President and Chief Executive Officer, Director |
FLXN | Flexion Therapeutics Inc | Nov 19, 2021 | 9 | -$339K | 4 | Nov 19, 2021 | Director |
FLXN | Flexion Therapeutics Inc | Jun 24, 2021 | 2 | $0 | 4 | Jun 28, 2021 | Director |